Keyphrases
Ulcerative Colitis
100%
Response Predictors
100%
Infliximab
100%
Infliximab Therapy
100%
Safety Self-efficacy
100%
Multicenter Retrospective Study
100%
Efficacy Predictor
100%
Confidence Interval
80%
Odds Ratio
80%
Clinical Remission
60%
Adverse Events
40%
Clinical Response
40%
Immunomodulator
40%
Multivariate Analysis
20%
Korean Patients
20%
Nave
20%
C-reactive Protein
20%
Response Rate
20%
Steroid Use
20%
Significant Predictors
20%
Long-term Clinical Outcome
20%
Adult Patients
20%
Best Response
20%
Moderate to Severe
20%
Refractoriness
20%
Mucosal Healing
20%
C-reactive
20%
Lack of Response
20%
Remission Rate
20%
Long-term Response
20%
Severe Ulcerative Colitis
20%
Ulcerative Colitis Patient
20%
Retrospective multicenter Study
20%
Acute Severe Ulcerative Colitis
20%
Active Ulcerative Colitis
20%
Medicine and Dentistry
Retrospective Study
100%
Infliximab
100%
Ulcerative Colitis
100%
Odds Ratio
50%
Adverse Event
25%
Immunomodulating Agent
25%
Multivariate Analysis
12%
C Reactive Protein
12%
Infusion
12%
Spontaneous Remission
12%
Patient with Ulcerative Colitis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Retrospective Study
100%
Infliximab
100%
Ulcerative Colitis
100%
Remission
37%
Adverse Event
25%
Immunomodulating Agent
25%
C Reactive Protein
12%
Immunology and Microbiology
Ulcerative Colitis
100%
Infliximab
100%
Immunomodulating Drugs
25%
C-Reactive Protein
12%